High-Affinity Interactions between Human α1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the α1L-Adrenoceptor
Authors:
- I. Craig CarrICI. Craig Carr
- John PedianiJPJohn Pediani
- Juan F. Lopez-GimenezJLJuan F. Lopez-Gimenez
- Richard ThurlowRTRichard Thurlow
- Mark FidockMFMark Fidock
- Graeme MilliganGMGraeme Milligan
- 1 August 2004
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 66 (2) , 228-239
Abstract
Using combinations of bioluminescence resonance energy transfer, time-resolved fluorescence resonance energy transfer and the functional complementation of pairs of inactive receptor-G protein fusion proteins, the human α1A-1-adrenoceptor was shown to form homodimeric/oligomeric complexes when expressed in human embryonic kidney (HEK) 293 cells. Saturation bioluminescence resonance energy transfer studies indicated the α1A-1-adrenoceptor homodimer interactions to be high affinity and some 75 times greater than interactions between the α1A-1-adrenoceptor and the δ opioid peptide receptor. Only a fraction of the α1A-1-adrenoceptors was at the plasma membrane of HEK293 cells at steady state. However, dimers of α1A-1-adrenoceptors were also present in intracellular membranes, and the dimer status of those delivered to the cell surface was unaffected by the presence of agonist. Splice variation can generate at least three forms of the human α1A-1-adrenoceptor with differences limited to the C-terminal tail. Each of the α1A-1, α1A-2a, and α1A-3a-adrenoceptor splice variants formed homodimers/oligomers, and all combinations of these splice variants were able to generate heterodimeric/oligomeric interactions. Despite the coexpression of these splice variants in human tissues that possess the pharmacologically defined α1L-adrenoceptor binding site, coexpression of any pair in HEK293 cells failed to generate ligand binding characteristic of the α1L-adrenoceptor.Keywords
This publication has 47 references indexed in Scilit:
- Oligomerization of the α1a- and α1b-Adrenergic Receptor SubtypesJournal of Biological Chemistry, 2003
- The ‘magic tail’ of G protein‐coupled receptors: an anchorage for functional protein networksFEBS Letters, 2003
- Principles: Extending the utility of [35S]GTPγS binding assaysTrends in Pharmacological Sciences, 2003
- Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy TransferJournal of Biological Chemistry, 2002
- Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy TransferJournal of Biological Chemistry, 2002
- Oligomerization of G-protein-coupled Receptors Shown by Selective Co-immunoprecipitationJournal of Biological Chemistry, 2002
- Measurement of Agonist-Dependent and -Independent Signal Initiation of α1b-Adrenoceptor Mutants by Direct Analysis of Guanine Nucleotide Exchange on the G Protein Gα11The Journal of Pharmacology and Experimental Therapeutics, 2002
- Protein–protein interactions at G-protein-coupled receptorsTrends in Pharmacological Sciences, 2001
- Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)Proceedings of the National Academy of Sciences, 2000
- Agonist Occupation of an α2A-Adrenoreceptor-Gi1α Fusion Protein Results in Activation of Both Receptor-linked and Endogenous Gi ProteinsJournal of Biological Chemistry, 1998